Lentitek
Edinburgh, GB · 2 known investors
Lentitek develops an alternative lentiviral vector production platform based on novel synthetic promoter technology, aimed at improving quality and yield in CAR-T manufacture and enabling in-vivo and armoured CAR applications. It works with advanced therapy (ATMP) asset developers through a serviced CRO license model to integrate and validate its vector solution.
Founders & leadership
AI
Adam IncheFounder
L
LeifCo-founder / Board member
JC
John CounsellChief Scientific Officer
Investors · 2
Companies House · registry record
View on Companies House ↗- Registered name
- LENTITEK LTD
- Company number
- SC633239
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 12 Jun 2019
- Registered office
- Floor 3, 1-4 Atholl Crescent, Edinburgh, EH3 8HA
- Nature of business (SIC)
- 21100 — Manufacture of basic pharmaceutical products71200 — Technical testing and analysis72110 — Research and experimental development on biotechnology74909 — Other professional, scientific and technical activities n.e.c.
- Accounts
- last made up to 30 Jun 2025 · next due 31 Mar 2027
- Confirmation statement
- last made up to 3 Jul 2026 · next due 17 Jul 2027
Current officers · 3
- Leif Crombie Anderson — director, appointed 5 Jun 2021
- Adam Grant Inche — director, appointed 12 Jun 2019
- Michael Lesley Roberts — director, appointed 29 Jul 2024
Source: Companies House public register · retrieved 5 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.